X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-14 | NGNE | Cobb Stuart | Chief Scientific Officer | S - Sale | $15.15 | -6,797 | 20,794 | -25% | -$103,003 | ||||||
2025-03-13 | NGNE | Cvijic Christine Mikail | Pres, CFO | S - Sale | $16.94 | -4,501 | 72,343 | -6% | -$76,247 | ||||||
2024-11-26 | NGNE | Samsara Biocapital Gp, LLC | 10% | P - Purchase | $25.83 | +48,770 | 1,717,127 | +3% | +$1,259,623 | ||||||
2024-11-22 | NGNE | Cvijic Christine Mikail | Pres, CFO | P - Purchase | $20.48 | +24,000 | 76,844 | +45% | +$491,400 | ||||||
2024-11-22 | NGNE | McMinn Rachel | CEO | P - Purchase | $20.40 | +47,500 | 1,297,859 | +4% | +$969,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |